Logo image
Back
Whole blood use in patients with traumatic brain injury and hemorrhagic shock is not associated with decreased mortality
Journal article   Peer reviewed

Whole blood use in patients with traumatic brain injury and hemorrhagic shock is not associated with decreased mortality

Nina L. Eng, Chan Shen, Sandeep Pradhan, Joshua P. Hazelton, Matthew J. Martin, Uyen Nguyen, Scott B. Armen, John S. Oh and the EAST Whole Blood Multicenter Collaborative
The journal of trauma and acute care surgery, v 99(3S), pp S39-S44
Aug 2025
DOI: https://doi.org/10.1097/TA.0000000000004730
PMID: 40587336
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1097/TA.0000000000004730View
Published, Version of Record (VoR) Open

Abstract

Critical Care Medicine General & Internal Medicine Life Sciences & Biomedicine Science & Technology Surgery
BACKGROUND Traumatic brain injury (TBI) is a leading cause of trauma mortality worldwide. Whole blood (WB) is associated with decreased mortality compared with blood component therapy (BCT) alone in trauma patients with hemorrhagic shock (HS). The ideal resuscitation approach in patients with both TBI and HS remains unclear. We hypothesize that resuscitation with WB in trauma patients with TBI and HS improves mortality. METHODS Using a prospective, multicenter, observational database, we examined a subset of patients with TBI and HS. We compared patients receiving BCT only for resuscitation with those receiving WB with BCT. We used chi(2) and Kruskal-Wallis tests to compare categorical and continuous variables by the use of WB. We conducted a multivariable logistic regression to examine the association between WB and mortality controlling for shock index, Injury Severity Score, age, sex, comorbid conditions, serious head injury, and mechanism of injury. RESULTS A total of 535 patients were included. One hundred thirty-five patients received BCT, and 400 patients received WB with BCT. There were no differences in the median Injury Severity Score, age, presence of comorbid conditions, proportion of serious head injury, or total component transfusions in the first 24 hours of admission (p > 0.05). More patients in the WB group were male, in shock, and experienced blunt trauma (p < 0.05). On multivariable logistic regression, WB use was not independently associated with lower mortality (odds ratio, 1.06; [95% confidence interval, 0.65-1.75]; p=0.809). CONCLUSION We identified no in-hospital mortality benefit of WB transfusion in addition to BCT in trauma patients with TBI and HS. Further research is needed into optimal resuscitation strategies for these patients.

Metrics

8 Record Views
2 citations in Web of Science

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Critical Care Medicine
Surgery
Logo image